http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57118573-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfc033f059d282fcd915bc8be2ae53f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 1981-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a852f0bb6cf146064e97ac4d83c53d8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f2328df2d5c80bcca8be8d0da264cf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aa00900debd628d599b67af5eb8788f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d89250681cea4da1fafc753b8d11bbaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee822894db48737413ec6cef72ed6d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc16967a845efdb81ccbf945eb9eecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27b719366e74be513776ed1e71cf750c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0382ca461e53e27c8e554c857ab16a53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d94985ec5e01c025c603bad9abb8ba
publicationDate 1982-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57118573-A
titleOfInvention N-(2-thiazolyl)carbamate derivative, its preparation, and drug composition comprising it
abstract NEW MATERIAL:An N-(2-thiazolyl)carbamate derivative shown by the formulaI (R is H, lower alkyl, cycloalkyl, thienyl, furyl, pyridyl). n EXAMPLE: 2,2,2-Trichloroethyl N-[4-(4-pyridyl)thiazole-2-yl)carbamate. n USE: A drug effective for immune diseases such as rheumatoid arthrits, also useful for viral diseases or carcinostatic immunotherapy, having immune adjusting ability and antarthritic action. Having low toxicity. n PROCESS: For example, an aminothizole shown by the formula II is reacted with 2,2-chloroformic acid 2,2,2-tricyloroethyl ester in a solvent such as benzene, etc., to give a compound shown by the formulaI. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1981-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13131956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236447168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412932835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51869642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395306

Total number of triples: 41.